Ledermann, J. A.; Matias-Guiu, X.; Amant, F.; Concin, N.; Davidson, B.; Fotopoulou, C.; Gonzalez-Martin, A.; Gourley, C.; Leary, A.; Lorusso, D.; Banerjee, S.; Chiva, L.; Cibula, D.; Colombo, N.; Croce, S.; Eriksson, A. G.; Falandry, C.; Fischerova, D.; Harter, P.; Joly, F.; Lazaro, C.; Lok, C.; Mahner, S.; Marme, F.; Marth, C.; McCluggage, W. G.; Mcneish, I. A.; Morice, P.; Nicum, S.; Oaknin, A.; Perez-Fidalgo, J. A.; Pignata, S.; Ramirez, P. T.; Ray-Coquard, I.; Romero, I.; Scambia, G.; Sehouli, J.; Shapira-Frommer, R.; Sundar, S.; Tan, D. S. P.; Taskiran, C.; van Driel, W. J.; Vergote, I.; Planchamp, F.; Sessa, C.; Fagotti, A.

There is no place for ovarian cancer screening in hereditary breast-ovarian cancer syndromes (in regard to ESMO Clinical Practice Guideline on risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes)

ANNALS OF ONCOLOGY

IF65.4

2024-01-010

PRE

Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey

ESMO OPEN

IF8.3

2023-04-018

OAAI

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line

BRITISH JOURNAL OF CANCER

IF6.8

2023-02-0915

OAAI

Colombo, N.; Gadducci, A.; Sehouli, J.; Rulli, E.; Maenpaa, J.; Sessa, C.; Montes, A.; Ottevanger, N. B.; Berger, R.; Vergote, I.; D'Incalci, M.; Galaz, C. Churruca; Chekerov, R.; Nyvang, G. B.; Riniker, S.; Herbertson, R.; Fossati, R.; Barretina-Ginesta, M. P.; Deryal, M.; Mirza, M. R.; Biagioli, E.; Iglesias, M.; Funari, G.; Romeo, M.; Tasca, G.; Pardo, B.; Tognon, G.; Rubio-Perez, M. J.; DeCensi, A.; De Giorgi, U.; Zola, P.; Panici, P. Benedetti; Aglietta, M.; Arcangeli, V.; Zamagni, C.; Bologna, A.; Westermann, A.; Heinzelmann-Schwarz, V.; Tsibulak, I.; Wimberger, P.; Poveda, A.

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline

ANNALS OF ONCOLOGY

IF65.4

2023-01-0181

OAAI

Phase I study of lurbinectedin in combination with weekly paclitaxel with or without bevacizumab in patients with advanced solid tumors

lurbinectedin与每周紫杉醇联合或不联合贝伐单抗治疗晚期实体瘤患者的I期研究

INVESTIGATIONAL NEW DRUGS

IF2.7

2022-08-108

OAAI

The Role of EUPATI CH in Promoting Patient Involvement in Clinical Research: A Multi-Stakeholder Research Project

FRONTIERS IN MEDICINE

IF3

2021-12-233

OAAI

Essential Package of Palliative Care for Women With Cervical Cancer: Responding to the Suffering of a Highly Vulnerable Population

JCO GLOBAL ONCOLOGY

IF3

2021-12-0124

OAAI

Krakauer, Eric L.; Kane, Khadidjatou; Kwete, Xiaoxiao; Afshan, Gauhar; Bazzett-Matabele, Lisa; Bien-Aime, Danta Dona Ruthnie; Borges, Lawrence F.; Byrne-Martelli, Sarah; Connor, Stephen; Correa, Raimundo; Devi, C. R. Beena; Diop, Mamadou; Elmore, Shekinah N.; Gafer, Nahla; Goodman, Annekathryn; Grover, Surbhi; Hasenburg, Annette; Irwin, Kelly; Kamdar, Mihir; Kumar, Suresh; Quynh Xuan Nguyen Truong; Randall, Tom; Rassouli, Maryam; Sessa, Cristiana; Spence, Dingle; Trimble, Ted; Varghese, Cherian; Fidarova, Elena

Augmented Package of Palliative Care for Women With Cervical Cancer: Responding to Refractory Suffering

JCO GLOBAL ONCOLOGY

IF3

2021-12-019

OAAI

Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studies

ESMO OPEN

IF8.3

2021-12-018

OAAI

Cervical Cancer-Associated Suffering: Estimating the Palliative Care Needs of a Highly Vulnerable Population

JCO GLOBAL ONCOLOGY

IF3

2021-12-0127

OAAI

Krakauer, Eric L.; Kwete, Xiaoxiao; Kane, Khadidjatou; Afshan, Gauhar; Bazzett-Matabele, Lisa; Bien-Aime, Danta Dona Ruthnie; Byrne-Martelli, Sarah; Connor, Stephen; Correa, Raimundo; Devi, C. R. Beena; Diop, Mamadou; Gafer, Nahla; Goodman, Annekathryn; Grover, Surbhi; Hasenburg, Annette; Irwin, Kelly; Khanh, Quach Thanh; Kumar, Suresh; Nevzorova, Diana; Truong, Quynh Xuan Nguyen; Rajagopal, M. R.; Randall, Tom; Rassouli, Maryam; Sessa, Cristiana; Spence, Dingle; Torode, Julie S.; Trimble, Ted; Varghese, Cherian; Fidarova, Elena

A phase I trial of lurbinectedin in combination with cisplatin in patients with advanced solid tumors

INVESTIGATIONAL NEW DRUGS

IF2.7

2021-08-285

PREAI

Clinical benefit of systemic therapies for recurrent ovarian cancer-ESMO-MCBS scores

全身治疗复发性卵巢癌的临床获益-esmo-mcbs评分

ESMO OPEN

IF8.3

2021-08-014

OAAI

Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey